Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

The scramble to save PhRMA's $80B deal
Fierce Pharma
Tuesday, March 16, 2010 - 10:22am
tags:
healthcare reform, PhRMA
3 Ways to Play the Obesity Drugs
TheStreet.com
Tuesday, March 16, 2010 - 10:05am
tags:
obesity, Arena Pharmaceuticals, Vivus, Orexigen, Contrave, Qnexa, lorcaserin
Hefty Allergan Sees Bullish Move
TheStreet.com
Tuesday, March 16, 2010 - 10:03am
tags:
Allergan
Bloodbath: SQNM Off 20%; No Financial Forecasts This Year, Looking for Cash
Barron's
Tuesday, March 16, 2010 - 10:01am
tags:
Sequenom
Sanofi-Aventis Pays $15M To Settle Discrimination Suit
Pharmalot
Tuesday, March 16, 2010 - 8:59am
tags:
discrimination, Sanofi, lawsuits
Novartis: No aliskiren benefit in heart attacks
Marketwatch
Tuesday, March 16, 2010 - 8:56am
tags:
Novartis, aliskiren, Tekturna
Drug Company CEO Compensation Makes as Little Sense This Year as It Did Last Year
BNET Pharma
Tuesday, March 16, 2010 - 8:52am
tags:
Pharma CEOs, executive pay
AstraZeneca says will be picky in emerging markets
Reuters
Tuesday, March 16, 2010 - 8:51am
tags:
emerging markets, AstraZeneca
Vanda, Titan Pharmaceuticals: 2 Biotech Stocks It Wouldn't Hurt to Own
Seeking Alpha
Tuesday, March 16, 2010 - 8:50am
tags:
Vanda, Titan
Lilly Buys Right to Underarm Lotion for Low Sex Drive
Bloomberg
Tuesday, March 16, 2010 - 8:40am
tags:
Acurox, Eli Lilly, testosterone
GTx ends Merck partnership, regains muscle drug
Yahoo/AP
Tuesday, March 16, 2010 - 8:38am
tags:
GTx, ostarine, Merck
Clinical Outcomes? Who Needs 'Em
Motley Fool
Tuesday, March 16, 2010 - 8:27am
tags:
Merck, Abbott Laboratories, Zetia, TriCor
Pfizer: More Lipitor cuts heart complications more
Yahoo/AP
Monday, March 15, 2010 - 7:00pm
tags:
Pfizer, Lipitor
GenVec Is Not Just a One Trick Pony
Seeking Alpha
Monday, March 15, 2010 - 6:26pm
tags:
GenVec, TNFerade, vaccines
What to Expect From Fred Hassan at Bausch & Lomb
BNET Pharma
Monday, March 15, 2010 - 4:22pm
tags:
Fred Hassan, Bausch & Lomb, Pharma CEOs, Schering Plough
Warning: Not All Boxed Warnings Are Equal
Motley Fool
Monday, March 15, 2010 - 4:21pm
tags:
black box, warnings, Plavix, Bristol-Myers Squibb, Biogen Idec, Elan, Tysabri, Sanofi
FDA Says "No Way!" Market Says "Yeah, Baby!"(Byetta)
Motley Fool
Monday, March 15, 2010 - 4:20pm
tags:
FDA, Amylin, Alkermes, Byetta, diabetes, Eli Lilly
Portola, Merck anticoagulant shows strong response
Bizjournals.com
Monday, March 15, 2010 - 4:18pm
tags:
anticoagulants, Portola Pharmaceuticals, Merck, betrixaban
Impax challenges patent on Abbott's Trilipix
Yahoo/AP
Monday, March 15, 2010 - 4:17pm
tags:
Impax, patents, Abbott Laboratories, Triplix
Roche, Pfizer cancer meds fail trials
Fierce Pharma
Monday, March 15, 2010 - 12:24pm
tags:
Roche, Pfizer, cancer, Sutent, Avastin

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.